Early treatment with ursodeoxycholic acid for cholestasis in children on parenteral nutrition because of primary intestinal failure

Alimentary Pharmacology and Therapeutics

Volumn 24, Issue 2, 2006, Pages 387-394

  De Marco, G ^a   Sordino, D ^a   Bruzzese, E ^a   Di Caro, S ^a   Mambretti, D ^a   Tramontano, A ^b   Colombo, C ^c   Simoni, P ^d   Guarino, A ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b SANTOBONO PAUSILIPON CHILDREN S HOSPITAL   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; URSODEOXYCHOLIC ACID;

ARTICLE; BILE ACID BLOOD LEVEL; CHILD; CHOLESTASIS; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; MALABSORPTION; MALE; PARENTERAL NUTRITION; PRIORITY JOURNAL; SHORT BOWEL SYNDROME;

CHOLAGOGUES AND CHOLERETICS; CHOLESTASIS; HUMANS; INFANT; INFANT, NEWBORN; INTESTINAL DISEASES; PARENTERAL NUTRITION; TREATMENT OUTCOME; URSODEOXYCHOLIC ACID;

EID: 33745679125     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.02972.x     Document Type: Article

References (29)

1. Goulet O. Intestinal failure in children. Transplant Proc 1998; 30: 2523-5.
2. Guarino A, De Marco G, Italian Network for Pediatric Intestinal Failure. Natural history of intestinal failure, investigated through a national network-based approach. J Pediatr Gastroenterol Nutr 2003; 37: 36-41.
3. Goulet O, Ruemmele F, Lacaille F, Colomb V. Irreversible intestinal failure. J Pediatr Gastroenterol Nutr 2004; 38: 250-69.
4. Kaufman SS, Atkinson JB, Bianchi A, et al. American Society of Transplantation. Indications for pediatric intestinal transplantation: a position paper for the American Society of Transplantation. Pediatr Transplant 2001; 5: 80-7.
5. Luman W, Shaffer JL. Prevalence, outcome and associated factors of deranged liver function tests in patients on home parenteral nutrition. Clin Nutr 2001; 21: 337-43.
6. Andorsky DJ, Lund DP, Lillehei CW, et al. Nutritional and other postoperative management of neonates with short bowel syndrome correlates with clinical outcomes. J Pediatr 2001; 139: 27-33.
7. Kaufman SS, Gondolesi GE, Fishbein TM. Parenteral nutrition associated liver disease. Semin Neonatol 2003; 8: 375-81.
8. Kaufman SS. Prevention of PN-associated liver disease in children. Pediatr Transplant 2002; 6: 37-42.
9. Beau P, Labat-labourdette J, Ingraud P, Beuchant M. Is ursodeoxycholic acid an effective therapy for total parenteral nutrition related liver disease? J Hepatol 1994; 20: 240-4.
10. Lindor KD, Burnes J. Ursodeoxycholic acid for the treatment home parenteral nutrition-associated cholestasis. Gastroenterology 1991; 101: 250-3.
11. Spagnuolo MI, Iorio R, Vegnente A, Guarino A. Ursodeoxycolic acid for treatment of cholestasis in children on long-term total parenteral nutrition: a pilot study. Gastroenterology 1996; 111: 716-9.
12. Heubi JE, Wiechmann DA, Creutzinger V, et al. Tauroursodeoxycholic acid (TUDCA) in the prevention of total parenteral nutrition-associated liver disease. J Pediatr 2002; 141: 237-42.
13. Bishop WP, Barber BA, Lichtman SN, Shneider BL. Another bear market disappointment? Ursodiol for TPN cholestasis. J Pediatr Gastroenterol Nutr 2003; 36: 422-3.
14. Walker S, Stiehl A, Raedsch R, Kloters P, Kommerell B. Absorption of urso-and chenodeoxycholic acid and their taurine and glycine conjugates in rat jejunum, ileum, and colon. Digestion 1985; 32: 47-52.
15. Paumgartner G, Beuers U. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology 2002; 36: 525-31.
16. Koletzko B, Goulet O, Hunt J, Krohn K, Shamir R, Parenteral Nutrition Guidelines Working Group; European Society for Clinical Nutrition and Metabolism; European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN); European Society of Paediatric Research (ESPR). Guidelines on Paediatric Parenteral Nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN), Supported by the European Society of Paediatric Research (ESPR). J Pediatr Gastroenterol Nutr 2005; 41S2: S1-87.
17. Simoni P, Cerré C, Cipolla A, et al. Bioavailability study of a new, sinking, enteric-coated ursodeoxycholic acid formulation. Pharmacol Res 1995; 31: 115-9.
18. Kocoshis SA, Beath SV, Booth IW, et al. North American Society for Gastroenterology, Hepatology and Nutrition. Intestinal failure and small bowel transplantation, including clinical nutrition: Working Group report of the second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2004; 39: S655-61.
19. Chen CY, Tsao PN, Chen HL, Chou HC, Hsieh WS, Chang MH. Ursodeoxycholic acid (UDCA) therapy in very-low birth-weight infants with parenteral nutrition-associated cholestasis. J Pediatr 2004; 145: 317-21.
20. Heine RG, Bines JE. New approaches to parenteral nutrition in infants and children. J Paediatr Child Health 2002; 38: 433-7.
21. Kelly DA. Liver complications of pediatric parenteral nutrition-epidemiology. Nutrition 1998; 14: 153-7.
22. Kumar D, Tandon R. Use of ursodeoxycholic acid in liver diseases. J Gastroenterol Hepatol 2001; 16: 3-14.
23. Lazaridis KN, Gores GJ, Lindor KD. Ursodeoxycholic acid mechanisms of action and clinical use in hepatobiliary disorders. J Hepatol 2001; 35: 134-46.
24. Cocjin J, Vanderhal A, Sehgal S. Ursodeoxycholic acid therapy for total parenteral nutrition-associated cholastasis in the neonate. Gastroenterology 1993; 104: 880.
25. Sandler RH, Maller ES, Meyers AF, Snyder JD, Kleinman RE. Use of ursodeoxycholic acid (UDCA) for children with severe liver disease from total parenteral nutrition (TPN): report of three cases. Pediatrics 1989; 25: 124.
26. Levine A, Maayan A, Shamir R, Dinari G, Sulkes J, Sirotta L. Parenteral nutrition-associated cholestasis in preterms neonates: evaluation of ursodeoxycholic acid treatment. J Pediatr Endocrinol Metab 1999; 12: 549-53.
27. Mitchell SA, Bansi DS, Hunt N, Von Bergmann K, Fleming KA, Chapman RW. A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis. Gastroenterology 2001; 121: 900-7.
28. Angulo P, Jorgensen RA, Lindor KD. Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile? Am J Gastroenterol 2001; 96: 3152-7.
29. Rost D, Rudolph G, Kloeters-Plachky P, Stiehl A. Effect of high-dose ursodeoxycholic acid on its biliary enrichment in primary sclerosing cholangitis. Hepatology 2004; 40: 693-8.